Medicine and Dentistry
Aplastic Anemia
91%
Immunosuppressive Treatment
31%
Myelodysplastic Syndrome
28%
Thymocyte Antibody
25%
Hematopoietic Stem Cell Transplantation
24%
Stem Cell
19%
Paroxysmal Nocturnal Hemoglobinuria
16%
Conditioning
16%
Hematopoietic Cell
16%
Overall Survival
15%
Bone Marrow Failure
14%
Graft Versus Host Reaction
12%
Allogeneic Hematopoietic Stem Cell Transplantation
12%
Pancytopenia
11%
Cyclosporine
11%
Alemtuzumab
11%
Acute Myeloid Leukemia
10%
Allogeneic Stem Cell Transplantation
10%
Diseases
10%
Platelet
7%
Disease
7%
Epstein Barr Virus
7%
Somatic Mutation
7%
Sulfhemoglobinemia
7%
Clinical Significance
6%
Multiple Sclerosis
6%
Cell Transplantation
6%
Matched Donor
6%
Chronic Graft Versus Host Disease
6%
Solid Malignant Neoplasm
6%
Donor Lymphocyte Infusion
5%
T Cell
5%
Bone Marrow Transplantation
5%
Immunology and Microbiology
Aplastic Anemia
100%
Hematopoietic Stem Cell Transplantation
24%
Alemtuzumab
24%
Anti-Thymocyte Globulin
24%
Conditioning
24%
Allogeneic Hematopoietic Stem Cell Transplantation
19%
Overall Survival
18%
Graft-Versus-Host Disease
17%
Immunosuppressive Therapy
16%
Hematopoietic Cell
15%
Stem Cell
14%
Allogeneic Stem Cell Transplantation
13%
Ciclosporin
12%
Regulatory T Cell
12%
Chronic Graft Versus Host Disease
11%
T Cell
9%
Viral Disease
9%
Lymphocyte
9%
Stem Cell Transplantation
8%
Platelet
7%
Immunosuppression
7%
Interleukin 2
7%
Clonal Evolution
7%
Autoimmune Disease
7%
Cyclophosphamide
6%
Immunosuppressive Drug
6%
Bone Marrow Transplantation
6%
Cell Transplantation
6%
Epstein Barr Virus
6%
Engraftment
6%
Prevalence
5%
Human Leukocyte Antigen
5%
Immunoglobulin Producing Cell
5%
Pharmacology, Toxicology and Pharmaceutical Science
Aplastic Anemia
60%
Thymocyte Antibody
22%
Alemtuzumab
21%
Immunosuppressive Agent
20%
Diseases
14%
Myelodysplastic Syndrome
12%
Bone Marrow Depression
11%
Ciclosporin
11%
Solid Malignant Neoplasm
10%
Pancytopenia
10%
Graft Versus Host Reaction
10%
Overall Survival
9%
Paroxysmal Nocturnal Hemoglobinuria
7%
Comorbidity
7%
Fludarabine
6%
Leukemia
6%
Nonhodgkin Lymphoma
6%
Neoplasm
6%
Acute Myeloid Leukemia
6%
Cyclophosphamide
5%
Disease Severity
5%
Chronic Graft Versus Host Disease
5%
Retrospective Study
5%
Aplasia
5%
Graft Failure
5%